Cholestatic liver disease
Information
- Disease name
- Cholestatic liver disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04168385 | Active, not recruiting | Phase 2 | MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study | January 16, 2020 | July 2024 |
| NCT04729751 | Active, not recruiting | Phase 2 | A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS). | September 9, 2021 | December 2024 |
| NCT04787419 | Active, not recruiting | Phase 2/Phase 3 | Probiotics in Pediatric Chronic Cholestasis | September 1, 2020 | December 1, 2023 |
| NCT01829698 | Completed | Phase 3 | Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBC | August 2009 | February 2014 |
| NCT05922332 | Not yet recruiting | N/A | Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease | February 2024 | June 2025 |
| NCT05045482 | Recruiting | Phase 1 | Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease | October 21, 2021 | July 2024 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002611
- MedGen concept unique identifier (MedGen Concept name)
- C0860204
- MedGen unique identifier (MedGen Concept name)
- 163651